News

HKUMed has achieved a significant breakthrough in developing needle-free, live-attenuated influenza vaccines with broad protection against human and ...
A Spanish study found that nirsevimab prophylaxis significantly reduced infant hospitalizations, ICU admissions, and severe ...
Scientists have engineered a monoclonal antibody that can protect mice from a lethal dose of influenza A, a new study shows. The new molecule combines the specificity of a mature flu fighter with the ...
Scientists have engineered a monoclonal antibody that can protect mice from a lethal dose of influenza A, a new study shows.
Moderna also hopes that combining the shots will help improve vaccine rates. Poland, however, is not sure people will like ...
Scientists have engineered a monoclonal antibody that can protect mice from a lethal dose of influenza A, a new study shows.
While the risk of contracting and dying from the H5N1 avian flu remains low for humans, researchers continue to hunt for ...
Cidara Therapeutics shifted its focus from antifungal treatments to its proprietary Cloudbreak drug Fc conjugate platform.
The US Department of Health and Human Services said Thursday that it aims to accomplish within four years a scientific feat ...
Vaccines save millions of lives every year, but there is still an urgent need for more efficient vaccines that target pathogens transmitted through the respiratory tract and may cause fatal infections ...